Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion description "[Ab-based CD73 cancer therapy should include a combination of Abs that target the catalytic activity of CD73, as well as those with the characteristics described in this article.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion evidence source_evidence_literature NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion SIO_000772 24043904 NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion wasDerivedFrom befree-20140225 NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_assertion wasGeneratedBy ECO_0000203 NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.
- befree-20140225 importedOn "2014-02-25" NP711699.RAa5OjGWW2gFCAlmtSXeepmeCXpWAA8JxgG0iRqmff0dU130_provenance.